Search
Search
Jorge Arroyo, MD, and Christina Kuemerle, BA
Show Description +
Jorge Arroyo, MD, wraps up surgery with DEXTENZA (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) to manage postoperative inflammation and pain, and enhance ocular lubrication. This punctal insert provides patients with sustained-release dexamethasone for 30 days, which helps simplify recovery by minimizing the need for eye drops—a crucial factor in improving patient compliance and comfort. Dr. Arroyo credits Dr. Eric Rosenberg for making the procedure look effortless with his expertise and technique. He says that DEXTENZA’s ability to provide consistent anti-inflammatory benefits and improve ocular lubrication is a game-changer in post-surgical care.
Posted: 11/08/2024
Jorge Arroyo, MD, and Christina Kuemerle, BA
Jorge Arroyo, MD, wraps up surgery with DEXTENZA (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) to manage postoperative inflammation and pain, and enhance ocular lubrication. This punctal insert provides patients with sustained-release dexamethasone for 30 days, which helps simplify recovery by minimizing the need for eye drops—a crucial factor in improving patient compliance and comfort. Dr. Arroyo credits Dr. Eric Rosenberg for making the procedure look effortless with his expertise and technique. He says that DEXTENZA’s ability to provide consistent anti-inflammatory benefits and improve ocular lubrication is a game-changer in post-surgical care.
Posted: 11/08/2024
![[2019] Amniotic Membrane Placement for Repair of Recurrent Macular Hole](https://d33x7gwyb2b5z6.cloudfront.net/eyetube/thumbs/gldaw.jpg?auto=compress,format&w=180)
Please log in to leave a comment.